Literature DB >> 6433814

Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population.

B M de Jongh, L K van Romunde, H A Valkenburg, G G de Lange, J J van Rood.   

Abstract

This report deals with the question of whether or not the established association of HLA-DR4 with rheumatoid arthritis (RA) can also be detected in cases of RA as diagnosed in a population survey. For this purpose 6584 persons older than 19 years living in a single community in The Netherlands were investigated for the presence of rheumatoid arthritis and related abnormalities. After five years 83 patients with RA, 30 with only erosive abnormalities on radiological examination (Rad), and 48 with only rheumatoid factor (RF) were reinvestigated and typed for HLA and allotypes of immunoglobulin G heavy chain (GM). On the classification of the initial survey no significant association of HLA-DR4 or GM could be detected in any of the three categories. When the information of the follow-up investigation was taken into account, a reappraisal of the classification resulted in 53 cases with RA, 18 with Rad only, and 35 with RF only. The frequencies of HLA-DR4 and GM in the three categories were also about the same as those in normal controls. However, an increase in the frequency of HLA-DR4 was observed in cases of RA positive for Rad, RF, or both. We found no evidence for an interaction between HLA-DR4 and GM. Our results suggest that rheumatoid arthritis is a heterogeneous disorder, only a fraction of which is associated with HLA-DR4. At present no single determinant of RA such as Rad or RF can characterise the HLA-DR4-associated, and most probably more severe, type of RA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433814      PMCID: PMC1001421          DOI: 10.1136/ard.43.4.613

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Rheumatoid arthritis in a population sample.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1956-03       Impact factor: 19.103

3.  HLA--Dw4 and rheumatoid arthritis.

Authors:  M Thomsen; N Morling; E Snorrason; A Svejgaard; S F Sørensen
Journal:  Tissue Antigens       Date:  1979-01

Review 4.  HL-A antigens and disease. Statistical and genetical considerations.

Authors:  A Svejgaard; C Jersild; L S Nielsen; W F Bodmer
Journal:  Tissue Antigens       Date:  1974

5.  Gene frequencies in a Dutch population.

Authors:  G R Fraser; W S Volkers; L F Bernini; E van Loghem; P Meera Khan; L E Nijenhuis
Journal:  Hum Hered       Date:  1974       Impact factor: 0.444

6.  HLA-DRw4 and rheumatoid arthritis.

Authors:  G Husby; J T Gran; M Ostensen; A Johannessen; E Thorsby
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

7.  HLA-DRW4 and prognosis in rheumatoid arthritis.

Authors:  I M Roitt; M Corbett; H Festenstein; D Jaraquemada; C Papasteriadis; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

8.  HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.

Authors:  F Speerstra; P Reekers; L B van de Putte; J P Vandenbroucke; J J Rasker; D J de Rooij
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

9.  Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study.

Authors:  A Cats; H M Hazevoet
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

10.  Mixed lymphocyte reaction in healthy women with rheumatoid factor. Lack of association with HLA-Dw4.

Authors:  E G Engleman; E E Sponzilli; M E Batey; S Ramcharan; H O McDevitt
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug
View more
  16 in total

Review 1.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  The familial nature of rheumatoid arthritis.

Authors:  C M Deighton; D J Walker
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

Review 3.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 4.  Should patients with recent onset rheumatoid arthritis be offered genetic screening?

Authors:  D P Symmons; W E Ollier; P Brennan; A J Silman
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

5.  DR4 prevalence related to the age at disease onset in female patients with rheumatoid arthritis.

Authors:  J M Hazes; B A Dijkmans; J M Hoevers; J J Janson; R R de Vries; J P Vandenbroucke; A Cats
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

6.  HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study; final report. Swiss Federal Commission for the Rheumatic Diseases, Subcommission for Research.

Authors: 
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 7.  Epidemiological approaches to the immunogenetics of autoimmune rheumatic disease.

Authors:  A J MacGregor; A J Silman
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

8.  Smoking, lung function, and rheumatoid factors.

Authors:  T Tuomi; M Heliövaara; T Palosuo; K Aho
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

9.  A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis.

Authors:  N de Vries; C F Prinsen; E B Mensink; P L van Riel; M A van't Hof; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

10.  Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community.

Authors:  W Thomson; L Pepper; A Payton; D Carthy; D Scott; W Ollier; A Silman; D Symmons
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.